首 页
医药产品
医保药品
中标目录
医药招标
数据中心
医学资料
医药新闻
医药展会
OTC药品
保健品
医疗器械
处方药
专科药
中医药
器械中标目录
药品批发行情
求购信息
医药下载
药价简讯
当前位置:药药网 / 药品 / 美国NDC复合药物数据库文件(本栏目收费,不能显示细节,电话13136136841)
药品名称:
商品名称:
药品NDC:
报告期内:
-
格式:2020-5-3
NDC包装id:
市场分类:
不限
ANDA
BLA
NDA
EMERGENCY USE AUTHORIZATION
NDA AUTHORIZED GENERIC
OTC MONOGRAPH FINAL
OTC MONOGRAPH NOT FINAL
UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE
UNAPPROVED DRUG OTHER
UNAPPROVED HOMEOPATHIC
UNAPPROVED MEDICAL GAS
活性成分:
持证企业:
美国药品NDC(国家药品编码)与药品说明书数据库
美国NDC未完成药物数据库文件
美国NDC复合药物数据库文件
美国NDC 数据库排除药物数据库文件
 美国NDC复合药物数据库文件1279条(本栏目收费,不能显示细节,电话13136136841)
药品名称(分析)
商品名
药品NDC
专利人(分析)
报告期内
活性成分
市场分类
规格(分析)
NDC包装id
Fentanyl 2 mcg/mL and Bupivacaine 0.125% PF in 0.9% Sodium Chloride
HUMAN COMPOUNDED DRUG
70004-231
SCA Pharmaceuticals, LLC
2021/2/1 0:00:00
FENTANYL CITRATE; BUPIVACAINE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
.002 mg/1 mL; 1.25 mg/1 mL
70004-231-64
Fentanyl 2 mcg/mL and Ropivacaine 0.2% in 0.9% Sodium Chloride PF
HUMAN COMPOUNDED DRUG
70004-260
SCA Pharmaceuticals, LLC
2021/2/1 0:00:00
FENTANYL CITRATE; ROPIVACAINE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
.002 mg/1 mL; 2 mg/1 mL
70004-260-32
Lidocaine 1% PF
HUMAN COMPOUNDED DRUG
70004-720
SCA Pharmaceuticals, LLC
2021/2/1 0:00:00
LIDOCAINE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
10 mg/1 mL
70004-720-12
Bevacizumab
HUMAN COMPOUNDED DRUG
71449-091
Denver Solutions, LLC dba Leiters Health
2021/2/1 0:00:00
BEVACIZUMAB
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
25 mg/1 mL
71449-091-43
Bevacizumab
HUMAN COMPOUNDED DRUG
71449-091
Denver Solutions, LLC dba Leiters Health
2021/2/1 0:00:00
BEVACIZUMAB
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
25 mg/1 mL
71449-091-44
Bevacizumab
HUMAN COMPOUNDED DRUG
71449-091
Denver Solutions, LLC dba Leiters Health
2021/2/1 0:00:00
BEVACIZUMAB
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
25 mg/1 mL
71449-091-98
Ketamine
HUMAN COMPOUNDED DRUG
71449-068
Denver Solutions, LLC dba Leiters Health
2021/2/1 0:00:00
KETAMINE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
10 mg/1 mL
71449-068-32
Ketamine
HUMAN COMPOUNDED DRUG
71449-068
Denver Solutions, LLC dba Leiters Health
2021/2/1 0:00:00
KETAMINE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
10 mg/1 mL
71449-068-11
Fentanyl Citrate
HUMAN COMPOUNDED DRUG
71449-013
Denver Solutions, LLC dba Leiters Health
2021/2/1 0:00:00
FENTANYL CITRATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
50 ug/1 mL
71449-013-32
Trophamine 2% / Dextrose 10% With Calcium Gluconate 2.33mEq and Heparin 125 units 250ml in 250ml bag
HUMAN COMPOUNDED DRUG
71285-0425
Central Admixture Pharmacy Services, Inc.
2021/2/1 0:00:00
LYSINE ACETATE; SERINE; GLUTAMIC ACID; TYROSINE; N-ACETYLTYROSINE; THREONINE; CYSTEINE HYDROCHLORIDE; HISTIDINE; ARGININE; TAURINE; DEXTROSE MONOHYDRATE; CALCIUM GLUCONATE MONOHYDRATE; LEUCINE; METHIONINE; PROLINE; ASPARTIC ACID; ISOLEUCINE; ALANINE; GLYCINE; PHENYLALANINE; TRYPTOPHAN; VALINE; HEPARIN SODIUM
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
.6 g/250 mL; .19 g/250 mL; .25 g/250 mL; .022 g/250 mL; .12 g/250 mL; .21 g/250 mL; .012 g/250 mL; .24 g/250 mL; .6 g/250 mL; .0125 g/250 mL; 25 g/250 mL; 2.33 meq/250 mL; .7 g/250 mL; .17 g/250 mL; .34 g/250 mL; .16 g/250 mL; .41 g/250 mL; .27 g/250 mL; .18 g/250 mL; .24 g/250 mL; .1 g/250 mL; .39 g/250 mL; 125 U/250 mL
71285-0425-1
Maintenance 4 to 1 Low K (36 mEq) Low Tromethamine 1000ml Bag
HUMAN COMPOUNDED DRUG
71285-0104
Central Admixture Pharmacy Services, Inc.
2021/2/1 0:00:00
CITRIC ACID MONOHYDRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; ANHYDROUS DEXTROSE; SODIUM CHLORIDE; TROMETHAMINE; POTASSIUM CHLORIDE; DEXTROSE MONOHYDRATE; TRISODIUM CITRATE DIHYDRATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
1.9947 g/1000 mL; 1.3542 g/1000 mL; 28.304 g/1000 mL; 27.2 meq/1000 mL; 4.428 g/1000 mL; 36 meq/1000 mL; 68.2 g/1000 mL; 16.043 g/1000 mL
71285-0104-1
Maintenance 8 to1 Low K (24 mEq) 500ml Bag
HUMAN COMPOUNDED DRUG
71285-0105
Central Admixture Pharmacy Services, Inc.
2021/2/1 0:00:00
CITRIC ACID MONOHYDRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; ANHYDROUS DEXTROSE; TRISODIUM CITRATE DIHYDRATE; SODIUM CHLORIDE; TROMETHAMINE; POTASSIUM CHLORIDE; DEXTROSE MONOHYDRATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
1.5696 g/500 mL; 1.0656 g/500 mL; 22.272 g/500 mL; 12.624 g/500 mL; 10.4 meq/500 mL; 4.896 g/500 mL; 24 meq/500 mL; 36.272 g/500 mL
71285-0105-1
Diltiazem 125mg added to D5W
HUMAN COMPOUNDED DRUG
72196-6054
Central Admixture Pharmacy Services, Inc.
2021/2/1 0:00:00
DILTIAZEM HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
125 mg/125 mL
72196-6054-1
Diltiazem 125mg added to NS
HUMAN COMPOUNDED DRUG
72196-6055
Central Admixture Pharmacy Services, Inc.
2021/2/1 0:00:00
DILTIAZEM HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
125 mg/125 mL
72196-6055-1
Heparin 4000units added to NS
HUMAN COMPOUNDED DRUG
72196-7022
Central Admixture Pharmacy Services, Inc.
2021/2/1 0:00:00
HEPARIN SODIUM
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
4000 U/1000 mL
72196-7022-1
Phenylephrine 10mg added to NS
HUMAN COMPOUNDED DRUG
72196-6058
Central Admixture Pharmacy Services, Inc.
2021/2/1 0:00:00
PHENYLEPHRINE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
10 mg/250 mL
72196-6058-1
Microplegia (MSA/MSG 0.92 Molar) with CP2D
HUMAN COMPOUNDED DRUG
71285-0012
Central Admixture Pharmacy Services, Inc.
2021/2/1 0:00:00
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; ANHYDROUS DEXTROSE; ASPARTIC ACID; GLUTAMIC ACID; CITRIC ACID MONOHYDRATE; TRISODIUM CITRATE DIHYDRATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
.00833 g/1 mL; .174 g/1 mL; .03769 g/1 mL; .04206 g/1 mL; .01226 g/1 mL; .09863 g/1 mL
71285-0012-2
Transplant Solution (Plasmalyte A, pH 7.4)
HUMAN COMPOUNDED DRUG
71285-0014
Central Admixture Pharmacy Services, Inc.
2021/2/1 0:00:00
ASPARTIC ACID; GLUTAMIC ACID; DEXTROSE MONOHYDRATE; SODIUM CHLORIDE; SODIUM GLUCONATE; SODIUM ACETATE; POTASSIUM CHLORIDE; MAGNESIUM CHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
.02193 g/1 mL; .03059 g/1 mL; .09036 g/1 mL; 2.39091 mg/1 mL; 2.28182 mg/1 mL; 1.67273 mg/1 mL; .16818 mg/1 mL; .13636 mg/1 mL
71285-0014-2
Calcium Gluconate 1gm added to 100ml NS
HUMAN COMPOUNDED DRUG
71285-6117
Central Admixture Pharmacy Services, Inc.
2021/2/1 0:00:00
CALCIUM GLUCONATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
1 g/100 mL
71285-6117-1
Oxytocin 30units added to NS
HUMAN COMPOUNDED DRUG
71285-6044
Central Admixture Pharmacy Services, Inc.
2021/2/1 0:00:00
OXYTOCIN
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
30 [USP'U]/500 mL
71285-6044-1
首页
(current)
40
(current)
41
(current)
42
(current)
43
(current)
44
(current)
45
(current)
46
(current)
47
(current)
48
(current)
49
(current)
(current)
末页
(current)
网站地图
-
网站开发
-
网站简介
-
会员服务
-
法律声明
-
联系我们
-
药品招商频道
-
药品信息排行
-
2018年版国家基本药物目录
-
意见反馈
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:
国家药品监督管理局
|
国家中医药管理局
|
SDA药品评审中心
|
医加医疗器械
|
膏药生产厂家
|
爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究 客服热线:0575-83552251 / 13754370441 QQ客服:
浙ICP备16010490号-2
增值电信业务经营许可证:
浙B2-20220931
互联网药品信息服务资格证书编号:
(浙)-经营性2023-0215
浙公网安备:330683240604819103159
医药代理商群1:
医药代理商群2:
医药代理商群3: